Tiverton Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$136K Hold
1,689
﹤0.01% 603
2019
Q2
$160K Buy
1,689
+603
+56% +$57.1K 0.01% 578
2019
Q1
$93K Sell
1,086
-139
-11% -$11.9K ﹤0.01% 589
2018
Q4
$69K Buy
+1,225
New +$69K ﹤0.01% 419